Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Chinese FDA gives approval to start LAIV vaccine clinical trials

Chinese FDA gives approval to start LAIV vaccine clinical trials September 24, 2015 • Category • Author Name

Chinese FDA gives approval to start LAIV vaccine clinical trials

Latest News

2024 Annual Report

November 18, 2024

2024 BioDiem AnnualReport

Read More
Notice of Annual General Meeting and Proxy Form

November 8, 2024

View the Notice of Annual General Meeting and Proxy Form

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions